AMICUS THERAPEUTICS, INC. — Director's Dealing 2015

Jul 15, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2015-07-13

Reporting Person: Valenzano Ken (SVP, Pharmacology & Biology)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-07-13	Common stock	M	9500	$15.00	Acquired	37187	Direct
2015-07-13	Common stock	S	9500	$15.00	Disposed	27687	Direct
2015-07-13	Common stock	M	2500	$15.00	Acquired	30187	Direct
2015-07-13	Common stock	S	2500	$15.00	Disposed	27687	Direct
2015-07-13	Common stock	M	3000	$15.00	Acquired	30687	Direct
2015-07-13	Common stock	S	3000	$15.00	Disposed	27687	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-07-13	Stock Options (right to buy)	$5.325	M	9500	Disposed	2016-02-28	Common Stock (9500)	Direct
2015-07-13	Stock Options (right to buy)	$4.16	M	2500	Disposed	2019-11-16	Common Stock (2500)	Direct
2015-07-13	Stock Options (right to buy)	$4.38	M	3000	Disposed	2022-06-04	Common Stock (3000)	Direct

Footnotes

F1: The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2015.